Parsolex expands cGMP manufacturing capacity in West Lafayette, Indiana

Parsolex has begun a capital investment program to expand its cGMP processing space by 33%, increase its analytical laboratory footprint by 50%, and add two new product-development suites at its facility in West Lafayette, Indiana.

“This flexibility has allowed us to maintain tableting, liquid, and automated capsule-filling technology to support both clinical and commercial production.”tabletscapsules.com

• 1 source
• tabletscapsules.comIndustry Application: Parsolex expands manufacturing capabilities | Tablets & Capsules MagazineMarch 06, 2020Mar 6, 2020

Summarized from public sources; check the original articles before acting on it.